Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 1/20 | 0.60 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.60 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.53 |
| ▸ | NQO2 | P16083 | 3/20 | 0.52 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.48 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.48 |
| ▸ | ESR1 | P03372 | 2/20 | 0.48 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.48 |
| ▸ | ESRRB | O95718 | 1/20 | 0.45 |
| ▸ | ESRRA | P11474 | 1/20 | 0.45 |
| ▸ | ANPEP | P15144 | 1/20 | 0.45 |
| ▸ | DPP4 | P27487 | 1/20 | 0.45 |
| ▸ | FLT3 | P36888 | 1/20 | 0.44 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.44 |
| ▸ | DAO | P14920 | 2/20 | 0.44 |
| ▸ | DDO | Q99489 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29418808 | 0.85 | IDH1 (0.54) | MTNR1AMTNR1BGABRA1GABRB2ESR1 | |
| SCHEMBL3952728 | 0.85 | IDH1 (0.54) | MTNR1AMTNR1BGABRA1GABRB2ESR1 | |
| SCHEMBL30727531 | 0.85 | IDH1 (0.54) | MTNR1AMTNR1BGABRA1GABRB2ESR1 | |
| SCHEMBL1034405 | 0.84 | MTNR1A (0.55) | MTNR1AMTNR1BMCL1NQO2ESR1 | |
| Hydrochloric Acid SCHEMBL30520083 | 0.83 | IDH1 (0.52) | MTNR1AMTNR1BGABRA1GABRB2ESR1 | |
| Hydrochloric Acid SCHEMBL30520291 | 0.83 | IDH1 (0.52) | MTNR1AMTNR1BGABRA1GABRB2ESR1 | |
| Hydrochloric Acid SCHEMBL29678754 | 0.83 | IDH1 (0.52) | MTNR1AMTNR1BGABRA1GABRB2ESR1 | |
| Hydroquinone SCHEMBL28096382 | 0.81 | GABRA1 (0.45) | MTNR1AMTNR1BGABRA1GABRB2ESR1 | |
| SCHEMBL12676044 | 0.81 | MTNR1A (0.53) | MTNR1AMTNR1BMCL1NQO2ESR1 | |
| SCHEMBL7103972 | 0.80 | TDP1 (0.66) | MTNR1AMTNR1BNQO2TRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7514520-B2 | Process for producing phosphonitrilic acid ester | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2009-04-07 | — | — | US | disclosed |
| US-20080091050-A1 | Process For Producing Phosphonitrilic Acid Ester | ASAHI KASEI CHEMICAL CORPORATION (JP) | 2008-04-17 | — | — | US | disclosed |
| US-20070060739-A1 | Process for producing phosphonitrilic acid ester | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2007-03-15 | — | — | US | disclosed |
| CN-1798753-A | Process for producing phosphonitrilic acid ester | ASAHI CHEMICAL CORP (JP) | 2006-07-05 | — | — | CN | disclosed |
| US-5780571-A | RESIN OBTAINED BY CONDENSATION OF NAPHTHOL AND 4,4*-BIS/CHLOROMETHYL/BIPHENYL, OPTIONALLY REACTED WITH EPICHLOROHYDRIN | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1998-07-14 | — | — | US | disclosed |
| EP-0644216-B1 | NAPHTHALENE-RING RESIN, RESIN COMPOSITION, AND CURED PRODUCT THEREOF | NIPPON KAYAKU KK (JP) | 1996-07-17 | — | — | EP | disclosed |
| EP-0644216-A1 | NAPHTHALENE-RING RESIN, RESIN COMPOSITION, AND CURED PRODUCT THEREOF | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1995-03-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080091050-A1 | Process For Producing Phosphonitrilic Acid Ester | PHOSPHO1, GNPAT, SELENOI | MTNR1A 2709/4885MTNR1B 2045/4885MCL1 1775/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.